.svg){kind=small}
Mar-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Apotho Therapeutics has shown a significant upward trajectory in the Massachusetts pre-roll category over the past few months. In December 2025, they were ranked 30th, but by March 2026, they had climbed to the 22nd position. This improvement in rank reflects a strategic push in their product offerings or market presence, as evidenced by their sales increase from $209,669 in December 2025 to $281,987 in March 2026. However, it's worth noting that they did not maintain a top 30 position in January 2026, which suggests some volatility or external challenges faced in that period.
Despite the fluctuation in rankings, the overall trend for Apotho Therapeutics in the pre-roll category in Massachusetts is positive, indicating resilience and potential growth opportunities. The leap from 41st in January to 25th in February suggests a strong recovery and possibly effective adjustments in their business strategies. While the specifics of these strategies are not detailed here, the data suggests that Apotho Therapeutics is gaining traction and could be a brand to watch in the coming months within the Massachusetts market.
Competitive Landscape
In the Massachusetts Pre-Roll category, Apotho Therapeutics has shown a notable improvement in its market position, moving from a rank of 30 in December 2025 to 22 by March 2026. This upward trend suggests a positive reception of their products, potentially driven by strategic marketing or product innovation. In contrast, Glorious Cannabis Co. experienced fluctuations, maintaining a rank around the 20s, which indicates a relatively stable but less dynamic market presence. Meanwhile, Fathom Cannabis and Root & Bloom have shown less volatility, with ranks mostly hovering in the 20s, suggesting steady sales without significant growth. Interestingly, Farmer's Cut saw a decline from 17 to 23, indicating a potential opportunity for Apotho Therapeutics to capture more market share if they continue their current trajectory. Overall, Apotho Therapeutics' recent performance highlights its potential to climb further up the ranks, especially if it can capitalize on the apparent stagnation or decline of some competitors.
Notable Products
In March 2026, the top-performing product for Apotho Therapeutics was Studio Pie Pre-Roll (1g), which climbed to the number one rank, achieving notable sales of 4,349 units. Following closely was Sour Gorilla Pre-Roll (1g) in the second position. Snow Devil Pre-Roll (1g) showed significant improvement, rising from fourth place in February to third in March, with sales increasing to 3,089 units. Gary's Eye Pre-Roll (1g) maintained a steady presence, securing the fourth rank, while Egg Nog Pre-Roll (1g) re-entered the top five, moving up to fifth place from its absence in February. The rankings indicate a dynamic shift in consumer preference, with Studio Pie Pre-Roll consistently outperforming other products in recent months.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
